Shock Wave Therapy Versus Neuromuscular Training in Women With Patellofemoral Pain

October 24, 2017 updated by: Piotr Michalik, Medical University of Silesia
The aim of the trial is to compare the efficacy of extracorporeal shock wave therapy (ESWT) versus neuromuscular training (TR) in reducing pain in women with patellofemoral pain (PFP). Women with PFP will be randomly divided into two therapeutic groups: ESWT and TR. The ESWT group will undergo extracorporeal shock wave therapy to the iliotibial band and tensor fascia latae. The TR group will be treated with neuromuscular training. The women's gait will be analysed and the strength of hip abductors and internal rotators will be measured. Additionally, the women's pain and health status will be assessed with the visual analogue scale and the Lysholm Scale. Outcomes will be registered at baseline, and then at five weeks and at three months post-therapy

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Śląskie
      • Katowice, Śląskie, Poland, 40-752
        • Recruiting
        • Department of Kinesitherapy and Special Methods, SHS in Katowice, Medical University of Silesia, Katowice, Poland

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

Knee pain for more than three months greater than three on the visual analogue scale (VAS) during at least two out of four typical activities:

  1. ascending or descending the stairs,
  2. prolonged sitting with flexed knee,
  3. running or jumping,
  4. squatting or kneeling.

Exclusion Criteria:

  1. Orthopaedic diagnosis other than PFP.
  2. Patients with neurological disorders, history of injury or operations within the symptomatic leg, rheumatoid disease, or pregnancy were also excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Neuromuscular Training
Each session lasted 30 minutes and consisted of three sets of exercises with 20-30 repetitions. Emphasis is placed on proper knee alignment during exercise. Most of the women exhibit excessive medial rotation and adduction of the femur, resulting in knee valgus. The women will be instructed how to correct their abnormalities using mirrors as visual feedback. All exercises will be completed without pain. If the exercises are too easy, the level of difficulty will be increased individually in accordance with the rehabilitation protocol
Each session lasted 30 minutes and consisted of three sets of exercises with 20-30 repetitions. Emphasis was placed on proper knee alignment during exercise. Most of the women exhibited excessive medial rotation and adduction of the femur, resulting in knee valgus, although knee varus was also observed. The women were instructed how to correct their abnormalities using mirrors as visual feedback. All exercises were completed without pain. If the exercises were too easy, the level of difficulty was increased individually in accordance with the rehabilitation protocol
Active Comparator: Shock Wave Therapy
The ESWT group will will meet the therapist twice in the first week, and once a week after it. ESWT will be applied to the iliotibial band and tensor fascia latae with the following parameters: pressure - 4.5 bar, emission frequency -8 Hz, number of pulses per dose -2,500 per session.
ESWT will be applied to the iliotibial band and tensor fascia latae muscle with the following parameters: pressure - 4.5 bar, emission frequency -8 Hz, number of pulses per dose -2,500 per session

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale is used to assess the subjective Pain.
Time Frame: Outcome measures are obtained at baseline (pre-intervention)
The participants are asked to make a mark on a 10 cm line that corresponds to the perceived maximal pain, peripatellar or retropatellar, they experienced during any activity or position (0 = no pain, 10 = the worst pain possible)
Outcome measures are obtained at baseline (pre-intervention)
Visual Analog Scale is used to assess the subjective Pain.
Time Frame: Outcome measures are obtained, at five weeks after intervention.
The participants are asked to make a mark on a 10 cm line that corresponds to the perceived maximal pain, peripatellar or retropatellar, they experienced during any activity or position (0 = no pain, 10 = the worst pain possible)
Outcome measures are obtained, at five weeks after intervention.
Visual Analog Scale is used to assess the subjective Pain.
Time Frame: Outcome measures are obtained at three months after intervention
The participants are asked to make a mark on a 10 cm line that corresponds to the perceived maximal pain, peripatellar or retropatellar, they experienced during any activity or position (0 = no pain, 10 = the worst pain possible)
Outcome measures are obtained at three months after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait analysis using the Zebris FDM-TDL instrumented treadmill with pressure sensors.
Time Frame: Outcome measures are obtained at baseline (pre-intervention)
The women walk on the treadmill barefoot for three minutes in order to become accustomed to the speed belt. After that time, the angles of the joints are measured for 30 seconds. Internal rotation is demarcated at the highest peak in midstance when the contralateral limb is in the terminal stance (toe-off phase). Hip adduction is determined at the highest peak in midstance
Outcome measures are obtained at baseline (pre-intervention)
Gait analysis using the Zebris FDM-TDL instrumented treadmill with pressure sensors.
Time Frame: Outcome measures are obtained, at five weeks after intervention.
The women walk on the treadmill barefoot for three minutes in order to become accustomed to the speed belt. After that time, the angles of the joints are measured for 30 seconds. Internal rotation is demarcated at the highest peak in midstance when the contralateral limb is in the terminal stance (toe-off phase). Hip adduction is determined at the highest peak in midstance
Outcome measures are obtained, at five weeks after intervention.
Gait analysis using the Zebris FDM-TDL instrumented treadmill with pressure sensors.
Time Frame: Outcome measures are obtained at three months after intervention
The women walk on the treadmill barefoot for three minutes in order to become accustomed to the speed belt. After that time, the angles of the joints are measured for 30 seconds. Internal rotation is demarcated at the highest peak in midstance when the contralateral limb is in the terminal stance (toe-off phase). Hip adduction is determined at the highest peak in midstance
Outcome measures are obtained at three months after intervention
Muscle strength is tested using the Micro Fet Handheld Dynamometer.
Time Frame: Outcome measures are obtained at baseline (pre-intervention)
Muscle strength of lateral rotators, abductors of the hip is tested. Three repetitions of muscle strength testing are performed with two 30-second intervals. The participants a of re asked to press against the Dynamometer with the maximum effort for 5-7 seconds.
Outcome measures are obtained at baseline (pre-intervention)
Muscle strength is tested using the Micro Fet Handheld Dynamometer.
Time Frame: Outcome measures are obtained, at five weeks after intervention.
Muscle strength of lateral rotators, abductors of the hip is tested. Three repetitions of muscle strength testing are performed with two 30-second intervals. The participants a of re asked to press against the Dynamometer with the maximum effort for 5-7 seconds.
Outcome measures are obtained, at five weeks after intervention.
Muscle strength is tested using the Micro Fet Handheld Dynamometer.
Time Frame: Outcome measures are obtained at three months after intervention
Muscle strength of lateral rotators, abductors of the hip is tested. Three repetitions of muscle strength testing are performed with two 30-second intervals. The participants a of re asked to press against the Dynamometer with the maximum effort for 5-7 seconds.
Outcome measures are obtained at three months after intervention
The self-reported health status is measured using the Lysholm Questionaire (LQ)
Time Frame: Outcome measures are obtained at baseline (pre-intervention)
The participants are asked to complete the eight-item questionnaire, scored on a 0-100 weighted scale
Outcome measures are obtained at baseline (pre-intervention)
The self-reported health status is measured using the Lysholm Questionaire (LQ)
Time Frame: Outcome measures are obtained, at five weeks after intervention.
The participants are asked to complete the eight-item questionnaire, scored on a 0-100 weighted scale
Outcome measures are obtained, at five weeks after intervention.
The self-reported health status is measured using the Lysholm Questionaire (LQ)
Time Frame: Outcome measures are obtained at three months after intervention
The participants are asked to complete the eight-item questionnaire, scored on a 0-100 weighted scale
Outcome measures are obtained at three months after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Mgdalena Dabrowska-Galas, PhD, Department of Kinesitherapy and Special Methods, SHS in Katowice, Medical University of Silesia, Katowice, Poland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2014

Primary Completion (Anticipated)

June 1, 2018

Study Completion (Anticipated)

January 1, 2019

Study Registration Dates

First Submitted

July 18, 2017

First Submitted That Met QC Criteria

October 24, 2017

First Posted (Actual)

October 27, 2017

Study Record Updates

Last Update Posted (Actual)

October 27, 2017

Last Update Submitted That Met QC Criteria

October 24, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • kolanostudentki

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

The datasets used and/or analysed during the current study will be available from the corresponding author on reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patellofemoral Pain Syndrome

Clinical Trials on Neuromuscular Training

Subscribe